- AVEO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Aveo Pharmaceuticals (AVEO) S-3Shelf registration
Filed: 7 May 15, 12:00am
Exhibit 12.1
Calculation of Consolidated Ratio/Deficiency of Earnings
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIO/DEFICIENCY OF
EARNINGS TO FIXED CHARGES
(dollars in thousands)
December 31, 2014 | December 31, 2013 | December 31, 2012 | December 31, 2011 | December 31, 2010 | ||||||||||||||||
Fixed Charges: | ||||||||||||||||||||
Interest expense on indebtedness, cash & non-cash | — | — | — | $ | 3,836 | — | ||||||||||||||
Interest portion of rental expense | — | — | — | 423 | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total Fixed Charges | — | — | — | $ | 4,259 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Earnings: | ||||||||||||||||||||
Net income before benefit for income taxes | — | — | — | $ | 30,648 | — | ||||||||||||||
Fixed charges per above | — | — | — | 4,259 | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total earnings | — | — | — | $ | 34,907 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Ratio of earnings to fixed charges(1) | — | — | — | 8.2 | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Deficiency of earnings available to cover fixed charges(2) | $ | (52,739 | ) | $ | (107,029 | ) | $ | (114,394 | ) | — | $ | (58,789 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
(1) | Our ratios of earnings to combined fixed charges and preferred stock dividends for the periods indicated above are the same as our ratios of earnings to fixed charges set forth above. |
(2) | We did not record earnings for any of the fiscal years ended December 31, 2014, 2013, 2012 and 2010. Accordingly, our earnings were insufficient to cover fixed charges for such periods and we are unable to disclose a ratio of earnings to fixed charges or ratio of earnings to combined fixed charges and preferred stock dividends for such periods. |